Q2 2013 Holdings
Filed 2013-08-15 | 11 holdings | $146.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medivation, Inc. | Com | 58501N101 | $123.2K | 2,504,101 | 84.3% |
| Ampio Pharmaceuticals Inc. | Com | 03209T109 | $7.6K | 1,308,455 | 5.2% |
| Alcobra Ltd | SHS | M2239P109 | $4.0K | 587,000 | 2.8% |
| Sequenom Inc. | Com New | 817337405 | $3.9K | 928,100 | 2.7% |
| Genworth Financial Inc.(GNW) | Com Cl A | 37247D106 | $3.7K | 320,000 | 2.5% |
| Vivus Inc.Call | Call | 928551900 | $1.4K | 5,000 | 1.0% |
| Newlink Genetics Corp | Com | 651511107 | $935 | 47,437 | 0.6% |
| Keryx Biopharmaceuticals Inc. | Com | 492515101 | $747 | 100,000 | 0.5% |
| Achillion Pharmaceuticals Inc.(ACHNEUR) | Com | 00448Q201 | $450 | 55,000 | 0.3% |
| Celgene Corp(CELG) | Com | 151020104 | $204 | 27,925 | 0.1% |
| Echo Therapeutics Inc. | Com New | 27876L206 | $111 | 444,445 | 0.1% |